Sun Pharma and Philogen sign global licensing agreement for Fibromun EP News Bureau Oct 1, 2024 Agreement focuses on global commercialisation of anti-cancer immunotherapy
Boehringer Ingelheim enters global licensing agreement to develop and commercialise antibodies from… EP News Bureau Jun 3, 2022 This partnership allows Boehringer Ingelheim to strengthen its tumour cell-directed Antibody-Drug Conjugate (ADC) and immune…
Dr Reddy’s Laboratories launches AVIGAN (favipiravir) in India EP News Bureau Aug 19, 2020 Dr Reddy’s AVIGAN comes in a pack of 122 tablets with a two-year shelf life
